Striatal dopamine in bulimia nervosa: A PET imaging study

International Journal of Eating Disorders

Volumn 45, Issue 5, 2012, Pages 648-656

  Broft, Allegra ^a,b   Shingleton, Rebecca ^a,b   Kaufman, Jenna ^a,b   Liu, Fei ^a,b   Kumar, Dileep ^a,b   Slifstein, Mark ^a,b   Abi Dargham, Anissa ^a,b   Schebendach, Janet ^a,b   Van Heertum, Ronald ^a   Attia, Evelyn ^a,b   Martinez, Diana ^a,b   Walsh, B Timothy ^a,b  

^a Columbia College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Addictions; Bulimia nervosa; Dopamine; Eating disorders; Pet imaging; Reward

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; METHYLPHENIDATE; RACLOPRIDE C 11;

ADULT; ANOREXIA NERVOSA; ARTICLE; BINGE EATING DISORDER; BULIMIA; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; DISEASE SEVERITY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; HUMAN; MEDICAL HISTORY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; SUBSTANCE ABUSE;

ADULT; BODY MASS INDEX; BRAIN MAPPING; BULIMIA NERVOSA; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; METHYLPHENIDATE; NEOSTRIATUM; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RECEPTORS, DOPAMINE D2;

EID: 84862784414     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.20984     Document Type: Article

References (35)

1. Wise RA. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 2006;361:1149-1158. (Pubitemid 44874226)
2. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009;56:3-8.
3. Davis C, Carter JC. Compulsive overeating as an addiction disorder. A review of theory and evidence. Appetite 2009;53:1-8.
4. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005;58:779-786. (Pubitemid 41677416)
5. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 2007;164:622-629. (Pubitemid 46650194)
6. Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, et al. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002;44:175-180. (Pubitemid 34303915)
7. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 2003;19:1709-1715. (Pubitemid 37025866)
8. Rada P, Avena NM, Hoebel BG. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 2005;134:737-744. (Pubitemid 41133378)
9. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010;13:635-641.
10. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 1992;49:132-138.
11. Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y, et al. Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci 2004;29:134-137. (Pubitemid 38570218)
12. Bohon C, Stice E. Reward abnormalities among women with full and subthreshold bulimia nervosa: A functional magnetic resonance imaging study. Int J Eat Disord 2011;44:585-595.
13. Frank GK, Wagner A, Achenbach S, McConaha C, Skovira K, Aizenstein H, et al. Altered brain activity in women recovered from bulimic-type eating disorders after a glucose challenge: a pilot study. Int J Eat Disord 2006;39:76-79. (Pubitemid 43130897)
14. First MB SR, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCIDP), version 2. New York: New York State Psychiatric Institute, Biometrics Research, 1995.
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
16. Fairburn CG, Cooper Z. The Eating Disorder Examination, 12th ed., in Binge Eating: Nature, Assessment and Treatment. In: Fairburn CG, Wilson GT, editors. New York: Guilford, 1993, pp. 317-360.
17. Hirvonen J, Karlsson H, Kajander J, Markkula J, Rasi-Hakala H, Nagren K, et al. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology (Berl) 2008;197:581-590.
18. Parsey RV, Oquendo MA, Zea-Ponce Y, Rodenhiser J, Kegeles LS, Pratap M, et al. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol Psychiatry 2001;50:313-322. (Pubitemid 32816943)
19. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001;21:1034-1057. (Pubitemid 32823740)
20. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse 2002;43: 181-187. (Pubitemid 34087672)
21. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 1997;94:2569-2574. (Pubitemid 27136916)
22. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536-546. (Pubitemid 23206731)
23. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153-158.
24. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007;27:1533-1539. (Pubitemid 47301451)
25. Slifstein M, Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 2001;28:595-608. (Pubitemid 32539407)
26. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990;347:146-151.
27. Schonberg T, Daw ND, Joel D, O'Doherty JP. Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making. J Neurosci 2007;27:12860-12867. (Pubitemid 350159584)
28. Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 2000;20:2369-2382. (Pubitemid 30230089)
29. Fudge JL, Breitbart MA, Danish M, Pannoni V. Insular and gustatory inputs to the caudal ventral striatum in primates. J Comp Neurol 2005;490:101-118. (Pubitemid 41140983)
30. Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008;322:449-452.
31. McClure SM, Berns GS, Montague PR. Temporal prediction errors in a passive learning task activate human striatum. Neuron 2003;38:339-346. (Pubitemid 36555658)
32. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003;23:285-300. (Pubitemid 36307573)
33. Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC, et al. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11C]raclopride. Biol Psychiatry 2005;58:908-912. (Pubitemid 41790720)
34. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 2000;20:423-451. (Pubitemid 30164887)
35. Levant B. The D-3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 1997;49:231-252. (Pubitemid 27414914)